Accept Refuse

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 32007R1352R(01)

Corrigendum to Commission Regulation (EC) No 1352/2007 of 16 November 2007 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Customs Tariff ( OJ L 303, 21.11.2007 )

OJ L 194, 23.7.2008, p. 42–44 (EN)

ELI: http://data.europa.eu/eli/reg/2007/1352/corrigendum/2008-07-23/oj

23.7.2008   

EN

Official Journal of the European Union

L 194/42


Corrigendum to Commission Regulation (EC) No 1352/2007 of 16 November 2007 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Customs Tariff

( Official Journal of the European Union L 303 of 21 November 2007 )

On page 4, in the Annex:

for:

‘ANNEX

In Chapter 15 of Annex I to Regulation (EEC) No 2658/87, Additional note 2 is amended as follows:

(1)

Additional note 2.B.1 is amended as follows:

(a)

Point (a) is replaced by the following:

“(a)

one of the following wax contents:

(i)

a wax content not more than 300 mg/kg or

(ii)

a wax content more than 300 mg/kg but not more than 350 mg/kg provided that:

the total aliphatic alcohol content is not more than 350 mg/kg or

the erythrodiol and uvaol content is not more than 3,5 %.”

(b)

Point (c) is replaced by the following:

“(c)

one of the following two characteristics:

(i)

a content in 2-glyceryl monopalmitate not more than 0,9 % if palmitic acid is not more than 14 % of the total content in fatty acids;

(ii)

a content in 2-glyceryl monopalmitate not more than 1,1 % if palmitic acid is not more than 14 % of the total content in fatty acids;”

(2)

Additional note 2.B.2 is amended as follows:

(a)

Point (ij) is replaced by the following:

“(ij)

one of the following two characteristics:

(i)

a content in 2-glyceryl monopalmitate not more than 0,9 % if palmitic acid is not more than 14 % of the total content in fatty acids;

(ii)

content in 2-glyceryl monopalmitate not more than 1,0 % if palmitic acid is not more than 14 % of the total content in fatty acids;”

(b)

Point (l) is replaced by the following:

“(l)

a content in stigmastadienes not more than 0,10 mg/kg;”

(3)

In additional note 2.C point (f) is replaced by the following:

“(f)

one of the following two characteristics:

(i)

a content in 2-glyceryl monopalmitate not more than 0,9 % if palmitic acid is not more than 14 % of the total content in fatty acids;

(ii)

a content in 2-glyceryl monopalmitate not more than 1,0 % if palmitic acid is not more than 14 % of the total content in fatty acids;”

(4)

In additional note 2.D points (a) – (d) are replaced by the following points (a) – (e):

“(a)

one of the following wax contents:

(i)

a wax content more than 350 mg/kg or

(ii)

a wax content more than 300 mg/kg but not more than 350 mg/kg provided that:

the total aliphatic alcohol content is more than 350 mg/kg and

the erythrodiol and uvaol content is more than 3,5 %.

(b)

an erythrodiol and uvaol content more than 4,5 %;

(c)

a content in 2-glyceryl monopalmitate not more than 1,4 %;

(d)

the sum of transoleic isomers not more than 0,20 % and the sum of translinoleic + translinolenic isomers not more than 0,10 %;

(e)

a difference between the HPLC and theoretical content of triglycerides with ECN42 of not more than 0,6.”

(5)

In additional note 2.E the second sentence is replaced by the following:

“Oils of this subheading must have a content in 2-glyceryl monopalmitate not more than 1,4 %, a sum of transoleic isomers of less than 0,4 %, a sum of translinoleic + translinolenic isomers of less than 0,35 % and a difference between the HPLC and theoretical content of triglycerides with ECN42 not more than 0,5.” ’

read:

‘ANNEX

In Chapter 15 of Annex I to Regulation (EEC) No 2658/87, Additional note 2 is amended as follows:

(1)

Additional note 2.B.1 is amended as follows:

(a)

Point (a) is replaced by the following:

“(a)

one of the following wax contents:

(i)

a wax content not exceeding 300 mg/kg; or

(ii)

a wax content exceeding 300 mg/kg but not exceeding 350 mg/kg provided that:

the total aliphatic alcohol content is less than or equal to 350 mg/kg, or

the erythrodiol and uvaol content is less than or equal to 3,5 %.”

(b)

Point (c) is replaced by the following:

“(c)

one of the following two characteristics:

(i)

a content in 2-glyceryl monopalmitate not exceeding 0,9 % if palmitic acid does not exceed 14% of the total content in fatty acids;

(ii)

a content in 2-glyceryl monopalmitate not exceeding 1,1 % if palmitic acid exceeds 14 % of the total content in fatty acids;”

(2)

Additional note 2.B.2 is amended as follows:

(a)

Point (ij) is replaced by the following:

“(ij)

one of the following two characteristics:

(i)

a content in 2-glyceryl monopalmitate not exceeding 0,9 % if palmitic acid does not exceed 14 % of the total content in fatty acids;

(ii)

a content in 2-glyceryl monopalmitate not exceeding 1,0% if palmitic acid exceeds 14% of the total content in fatty acids”;

(b)

Point (l) is replaced by the following:

“(l)

a content in stigmastadienes not exceeding 0,10 mg/kg;”

(3)

In additional note 2.C, point (f) is replaced by the following:

“(f)

one of the following two characteristics:

(i)

a content in 2-glyceryl monopalmitate not exceeding 0,9% if palmitic acid does not exceed 14% of the total content in fatty acids;

(ii)

a content in 2-glyceryl monopalmitate not exceeding 1,0% if palmitic acid exceeds 14% of the total content in fatty acids;”

(4)

In additional note 2.D, points (a) – (d) are replaced by the following points (a) – (e):

“(a)

one of the following wax contents:

(i)

a wax content higher than 350 mg/kg; or

(ii)

a wax content exceeding 300 mg/kg but not exceeding 350 mg/kg provided that:

the total aliphatic alcohol content is above 350 mg/kg, and

the erythrodiol and uvaol content is greater than 3,5 %.

(b)

an erythrodiol and uvaol content higher than 4,5 %;

(c)

a content in 2-glyceryl monopalmitate not exceeding 1,4 %;

(d)

the sum of transoleic isomers not exceeding 0,20 % and the sum of translinoleic + translinolenic isomers not exceeding 0,10 %;

(e)

a difference between the HPLC and theoretical content of triglycerides with ECN42 of 0,6 or less.”

(5)

In additional note 2.E the second sentence is replaced by the following:

“Oils of this subheading must have a content in 2-glyceryl monopalmitate not exceeding 1,4 %, a sum of transoleic isomers of less than 0,4 %, a sum of translinoleic + translinolenic isomers of less than 0,35 % and a difference between the HPLC and theoretical content of triglycerides with ECN42 not exceeding 0,5.” ’


Top